Official UK procurement notice
Next Gen Covid Pathogens Genomics (Congenica)
Authority: Department of Health & Social Care (Central government)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionDevelopment of Next Gen Covid Pathogens Genomics (Congenica)
CPV: Laboratory services
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Quality: 70%
- price: 20%
- Social: 10%
Published award criteria (3)
- Quality: 70
- Social: 10
- Price: 20
- Price carries 20 of 100 points: a 10% discount moves about 2 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Competitive procedure with negotiation
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Nov 2021, 22:17 GMT
- Last source update
- 25 Jul 2022, 16:31 BST
- FTS notice number
2022/S 000-020212- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02f532Find a Tender
Publisher note: Technical and Functional Service Requirements• The solution must be capable of accurately processing sequencer output (e.g. BAM/fastq), as well as assembled sequences, and of returning outputs within 4 hours of loading the sequence. • The solution must be capable of incorporating new algorithms into the per-sample sequencing pipeline on a short release cadence to meet evolving public health requirements.• Production and storage of assembled sequence and lineage assignation and variant data is required; these will allow the Authority to detect outbreaks of SARS-CoV-2.• The solution must have options to match a local sequence to global lists of Variants of Concern or other features.• The solution must enable users to upload, analyse and share identifiers necessary to identify genomes.• The solution must be capable of processing at least 100,000 samples a week and be able to ramp up this upwards if required.• A mechanism must exist such that during the upload process, the identifier stored and any other identifiable metadata available to the uploading laboratory (including the laboratory number of the specimen) are provided securely to a secure endpoint designated by the Authority. • The solution must be capable of storing and allowing interrogation of large volumes of processed sequence outputs providing results rapidly. At present, over 1 million sequences have been generated in the UK alone.• The solution must be capable of producing reports in standardised formats as well as generating new reports on an on-demand basis drawing upon information generated in the solution. • Interaction with the system, including data upload, download, querying of stored data, and reporting must be achievable by both fully automated means such as an authenticated REST API, and by interactive web interfaces.• The framework used by the solution must be demonstrably extensible to other pathogens. A plan will be required showing how pipelines processing up to 10 new pathogens could be introduced over the next 12 months using the same framework.• The solution must be able to ingest data from multiple sources including CLIMB-COVID, ENA, GISAID among other sources. The solution must be able to develop interfaces to ingest data from further sources that may be identified in the future. • The solution should allow secure and auditable sequence sharing, if the Authority elects to do so, with defined organisations which may be using the same system. Key Non-Functional Service Requirements• The solution must have a robust support wrapper to ensure continuity of service and the capability for failovers to avoid surveillance blackouts.• There is no requirement for this solution to provide a long-term archive of sequencer output (e.g. BAM/fastq) as part of the solution. By contrast, there is a requirement to store the outputs from analysis of this information.• There is no requirement for the solution to store any patient identifiable data. Samples in the system will be identified by an identifier provided during the upload process.• The solution provider, as data processor, must securely process, store or in transit, all data within the United Kingdom• The solution should be capable of user access management. • A plan must exist for accrediting the solution to ISO15189, ISO17025 or other relevant standards for diagnostic systems• The solution must minimally comply with the following standards: Cyber Security Essentials.
How it was run
Official noticeTender documents are also served through a separate tool: http://health.atamis.co.uk ↗
- Submission deadline
- —
Timeline
3 Jan 2022 → 25 Jul 2022 · 2 dates- Next notice expected3 Jan 2022
- Notice published25 Jul 2022, 16:31 BST
Notice history
3 events · 2 releases on Find a Tender · since 25 Jul 2022- Status changed to complete25 Jul 2022, 16:31 BST
- Procurement method changed25 Jul 2022, 16:31 BST
- Buyer details updated25 Jul 2022, 16:31 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| CongenicaSME | £11,135,800 † | — | Awarded |
Contracts
Contract 020212-2022-1 · CongenicaSME
- Signed
- 24 Jun 2022
- Value
- £11,135,800
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- UK Health Security AgencyContracting authorityMinistry or any other national or federal authority, including their regional or local subdivisionsHealth
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- CONGENICA LTDAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.